𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer

✍ Scribed by Amalia G. Bernal; Juan J. Cruz; Pedro Sánchez; Angel Muñoz; Adelaida Nieto; Emilio Fonseca; Rodoil Calle; J. Luis Gómez

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
425 KB
Volume
63
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of cisplatin and contin
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer
✍ Eduardo Tellez-Bernal; Gonzalo Recondo; Thierry Guillot; Mohamed Benhamed; Chris 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

The chemotherapeutic treatment of recurrent and/or metastatic squamous cell carcinoma (SCC) of the head and neck (H & N) has a very dismal prognosis, with survival usually not exceeding 1 year. Reported objective response rates vary between 3% and 70%. This difference appears largely attributable to

Concomitant cisplatin/5-FU infusion and
Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results
✍ Samuel G. Taylor IV; Anantha K. Murthy; Katherine L. Griem; Diane C. Recine; Kry 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

Background. The purpose of this study was to analyze long-term follow-up of a single institution's experience with a regimen of concomitant cisplatin/fluorouracil (5-FU) infusion and radiation given every other week. This analysis was stimulated by results of a randomized trial showing superiority f

Continuous infusion of 5-fluorouracil an
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
✍ Yong-Suk Chung; Yoshito Yamashita; Tohru Inoue; Tasuku Matsuoka; Bunzo Nakata; N 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

City Uni-11 cases, for an overall response rate of 50%. Patients with good performance versity Medical School, Osaka, Japan. status (PS) (0-1) and differentiated histologic type showed higher response rates (50.0% and 63.6%, respectively) than patients with poor PS (2 or 3) and undifferenti-2 Insti